AVAH
Get informed when a big investor buys or sells
+ FollowOvervalued by 148.3% based on the discounted cash flow analysis.
| Market cap | $2.07 Billion |
|---|---|
| Enterprise Value | $3.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.1 |
| Beta | 1.89 |
| Outstanding Shares | 214,595,000 |
| P/E Ratio | 7.49 |
|---|---|
| PEG | 15.25 |
| Price to Sales | 0.94 |
| Price to Book Ratio | 11.29 |
| Enterprise Value to Revenue | 1.33 |
| Enterprise Value to EBIT | 16.01 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 5.24 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 22.26%▼ 74.95% |
|---|---|
| Total Invested | $409.78M▼ 67.84% |
| Investors Holding | 67▼ 131.00% |
No data
Based in Atlanta, Georgia, Aveanna is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna directly addresses the most pressing challenges facing the U.S. health...